NCT01554293View on ClinicalTrials.gov

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

PHASE1UnknownINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

September 30, 2013

Conditions

Diabetes Mellitus

Interventions

DRUG

Matching placebo

Matching Placebo, single dose

DRUG

PBL 1427 capsules

PBL 1427 capsules 20 mg and 150 mg, single dose

Trial Locations (1)

121 002

RECRUITING

Fortis Clinical Research Ltd, Faridabad

Sponsors

Lead Sponsor

Panacea Biotec Ltd

All Listed Sponsors

lead

Panacea Biotec Ltd

INDUSTRY

NCT01554293 - Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers | Biotech Hunter | Biotech Hunter